title: Stimulation of testosterone production in the cynomolgus monkey in vivo by deglycosylated and desialylated human choriogonadotropin.
abstract: Modifications of carbohydrate structures of hCG, such as deglycosylation or desialylation, have been shown to reduce the biological activity of the hormone derivatives in vivo. We posed the question of whether deglycosylated hCG (dg-hCG) and desialylated hCG (ds-hCG) would behave as agonists at the LH/CG receptor in the primate in vivo, as this would bear on their potential clinical utility as LH/CG agonists or antagonists. Thus, we administered large doses (approximately 3 nmol) of highly purified dg-hCG, ds-hCG, hCG, or normal saline as a rapid iv injection to adult male cynomolgus monkeys (n = 3/group). Mean areas under the curves of plasma T over the first 6 h achieved with dg-hCG and ds-hCG were about 5-fold, significantly (P less than 0.05) greater than that in the saline controls and not significantly (P greater than 0.05) different from that in hCG-injected animals. Despite comparable plasma T responses in the first 6 h, mean plasma concentrations of ds-hCG, dg-hCG, and hCG differed dramatically among the groups. Plasma ds-hCG and dg-hCG levels were undetectable by 15 and 180 min, respectively, while the mean plasma hCG level was more than 2.10 nmol/L at 360 min. These data indicate that 1) dg-hCG is a full agonist at the LH/CG receptor in the primate in vivo, despite having minimal intrinsic activity in the rat Leydig cell adenyl cyclase assay and being able to near-completely antagonize hCG action therein; and 2) ds-hCG is a full agonist in the monkey in vivo, capable of stimulating a full testicular response over 6 h, despite being cleared from the circulation in 15 min. We conclude that the signal transduction system at the monkey LH/CG receptor is capable of achieving full steroidogenesis despite dramatically shortened exposure to stimulus or exposure to a stimulus with markedly reduced adenyl cyclase-stimulating activity in vitro.
authors.affiliation: Developmental Endocrinology Branch, National Institute of Child Health and Human Development, Bethesda, Maryland 20892.
authors.forename: L
authors.initials: L
authors.lastname: Liu
authors.forename: J L
authors.initials: JL
authors.lastname: Southers
authors.forename: S M
authors.initials: SM
authors.lastname: Banks
authors.forename: D L
authors.initials: DL
authors.lastname: Blithe
authors.forename: R E
authors.initials: RE
authors.lastname: Wehmann
authors.forename: J H
authors.initials: JH
authors.lastname: Brown
authors.forename: H C
authors.initials: HC
authors.lastname: Chen
authors.forename: B C
authors.initials: BC
authors.lastname: Nisula
mesh_terms: D000818:Animals; D001212:Asialoglycoproteins; D006063:Chorionic Gonadotropin / Q000097:blood / Q000493:pharmacokinetics / Q000494:pharmacology*; D007700:Kinetics; D008252:Macaca fascicularis; D008297:Male; D011974:Receptors, LH / Q000187:drug effects / Q000502:physiology; D015398:Signal Transduction; D013737:Testis / Q000187:drug effects / Q000378:metabolism; D013739:Testosterone / Q000097:blood*
chemical_list: D001212:Asialoglycoproteins; D006063:Chorionic Gonadotropin; C034923:HCG, deglycosylated; D011974:Receptors, LH; C019263:asialo-human chorionic gonadotropin; D013739:Testosterone